Candel Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
117 Kendrick Street, Suite 450, Needham, MA

Insiders trading volume in the past year

Candel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Estuardo Aguilar-Cordova 10%+ Owner $38.9M -$399K -1.02% Dec 26, 2024
Paul B. Manning Director $24.8M +$7.5M +43.4% Dec 16, 2024
Laura K. Aguilar 10%+ Owner $2.74M May 6, 2022
Paul Peter Tak Chief Executive Officer, Director $1.82M -$820K -31.1% Jan 15, 2025
Francesca Barone Chief Scientific Officer $800K -$477K -37.4% Jan 15, 2025
Seshu Tyagarajan Chief Technology Officer $699K -$492K -41.3% Jan 15, 2025
William Garrett Nichols Chief Medical Officer $573K -$356K -38.3% Jan 15, 2025
Charles Schoch Interim Chief Financial Officer $311K -$268K -46.3% Jan 15, 2025
Jason Amello Chief Financial Officer $182K Nov 28, 2023
Udi Meirav Director $43.9K Jul 26, 2021
Smith Alan E Director $29.3K Jul 26, 2021
Nathan Caffo Chief Business Officer $5.4K Jul 29, 2021
Shaan-Chirag C. Gandhi Director Jul 26, 2021
Susan B. Stewart Chief Regulatory Officer Apr 11, 2022
Renee Gaeta Director Jun 26, 2024
Edward J. Benz JR Director Jun 26, 2024
Diem Nguyen Director Jun 26, 2024
Joseph C. Papa Director Jun 26, 2024
Christopher Martell Director Jun 26, 2024
Nicoletta Loggia Director Jun 26, 2024
John Canepa Chief Financial Officer Feb 28, 2022
Gary J. Nabel Director Jun 26, 2024

Recent Insider Transactions by Companies or Individuals for Candel Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.